Can 'Bundle' Payment Plans Shield Against FCA Liability?

By Maurice Bellan and Aleesha Fowler (January 28, 2019, 5:18 PM EST) -- On Dec. 11, 2018, the United States Attorney's Office for the District of New Jersey submitted a statement of interest to a federal court, asking the court to rule on a specific question of law that implicates the scope of the materiality standard in False Claims Act jurisprudence: Whether a pharmaceutical company that violates the anti-kickback statute, or AKS, and causes a hospital to submit reimbursement claims for non-covered uses of a drug, can be held liable under the FCA if the federal government pays for the drug through a flat, bundled payment....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!